Ying-Hua Luo Selected Research

ENDMNQ

3/2019	Novel 1,4‑naphthoquinone derivatives induce reactive oxygen species‑mediated apoptosis in liver cancer cells.
1/2019	The design of 1,4-naphthoquinone derivatives and mechanisms underlying apoptosis induction through ROS-dependent MAPK/Akt/STAT3 pathways in human lung cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying-Hua Luo Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 12/2017
9	Lung Neoplasms (Lung Cancer) 01/2021 - 02/2018
8	Stomach Neoplasms (Stomach Cancer) 01/2020 - 08/2017
4	Hepatocellular Carcinoma (Hepatoma) 02/2021 - 01/2018
3	Breast Neoplasms (Breast Cancer) 11/2019 - 12/2017
2	Lymphoma (Lymphomas) 02/2019 - 02/2018
1	Carcinogenesis 12/2020
1	Melanoma (Melanoma, Malignant) 12/2019
1	Liver Neoplasms (Liver Cancer) 03/2019
1	Rheumatoid Arthritis 02/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 06/2018
1	Inflammation (Inflammations) 01/2018
1	Neuroinflammatory Diseases 07/2016

Drug/Important Bio-Agent (IBA)

9	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2020 - 01/2018
5	1,2,5,8-tetrahydroxy anthraquinoneIBA 12/2019 - 08/2017
4	1,4-naphthoquinoneIBA 01/2022 - 01/2018
4	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 03/2019 - 01/2018
3	Oxygen (Dioxygen)IBA 09/2019 - 02/2019
3	Mitogen-Activated Protein KinasesIBA 03/2019 - 01/2018
2	Biological ProductsIBA 01/2022 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2019
2	Sincalide FDA Link 12/2020 - 01/2020
2	EPDMNQIBA 03/2019 - 01/2019
2	ENDMNQIBA 03/2019 - 01/2019
2	Antineoplastic Agents (Antineoplastics)IBA 03/2019 - 01/2018
2	Phosphotransferases (Kinase)IBA 02/2019 - 01/2019
2	cryptotanshinoneIBA 02/2019 - 12/2017
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2019 - 01/2018
1	7,3'-dihydroxy-4'-methoxyisoflavoneIBA 02/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	AcidsIBA 01/2021
1	LigandsIBA 01/2021
1	cytisineIBA 12/2020
1	liquiritinIBA 10/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	ZeaxanthinsIBA 01/2020
1	Carotenoids (Carotene)IBA 01/2020
1	naphthaleneIBA 05/2019
1	Trypan Blue FDA Link 05/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 02/2019
1	glyciteinIBA 01/2019
1	IsoflavonesIBA 01/2019
1	isoliquiritigenin (GU 17)IBA 01/2019
1	JNK Mitogen-Activated Protein KinasesIBA 01/2019
1	Adenosine (Adenocard)FDA LinkGeneric 02/2018
1	NaphthoquinonesIBA 01/2018
1	p38 Mitogen-Activated Protein KinasesIBA 01/2018
1	Apoptosis Regulatory ProteinsIBA 12/2017
1	2,3-dimethoxy-1,4-naphthoquinoneIBA 07/2016

Therapy/Procedure

3	Therapeutics 01/2021 - 02/2018
1	Drug Therapy (Chemotherapy) 01/2021
1	Immunotherapy 01/2021
1	Radiotherapy 01/2021